Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants

By Rencher S.D.   Lockey T.D.   Srinivas R.V.   Owens R.J.   Hurwitz J.L.  

Vaccine, Vol. 15, Iss. 3, 1997-02 ,pp. : 265-272

Elsevier

Access to resources Recommend Favorite

A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation

By Caver T.E.   Lockey T.D.   Srinivas R.V.   Webster R.G.   Hurwitz J.L.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1567-1572

Elsevier

Access to resources Recommend Favorite

Enhanced CD8 + T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants

By Gonzalo R.M.   Rodrguez D.   Garca-Sastre A.   Rodrguez J.R.   Palese P.   Esteban M.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 887-892

Elsevier

Access to resources Recommend Favorite

Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates

By Lee S.A.   Orque R.   Escarpe P.A.   Peterson M.L.   Good J.W.   Zaharias E.M.   Berman P.W.   Sheppard H.W.   Shibata R.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 563-576

Elsevier

Access to resources Recommend Favorite

Chimeras between the human immunodeficiency virus (HIV-1) Env and vaccinia virus immunogenic proteins p14 and p39 generate in mice broadly reactive antibodies and specific activation of CD8+ T cell responses to Env

By Collado  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3123-3133

Elsevier

Access to resources Recommend Favorite